Pages

Sunday, August 14, 2011

'Huge' results raise hope for cancer breakthrough
In early results from a clinical trial, genetically engineered T cells eradicate leukemia cells and thrive. Two of three patients studied have been cancer-free for more than a year.

==============================================

By Eryn Brown, Los Angeles Times

August 11, 2011
In a potential breakthrough in cancer research, scientists at the University of Pennsylvania have genetically engineered patients' T cells — a type of white blood cell — to attack cancer cells in advanced cases of a common type of leukemia.

Two of the three patients who received doses of the designer T cells in a clinical trial have remained cancer-free for more than a year, the researchers said.